This is a must read. If you cannot see this email properly, please click [here]( Sponsor [Forget AI THIS is Way Bigger](
the world has been obsessed with AI and ChatGPT… Jeff Bezos has quietly gone all in on a technology that's going to prove to be FAR bigger. If you've never heard of "QaaS" technology you need to [click here now.](
--------------------------------------------------------------- Dear Reader, We just ran our screens and wanted to point out 6 'Strong Buy' Stocks that you might want to keep an eye on....Keep in mind, these are very volatile stocks so please do your own research before you make any investments. We are not recommending these stocks. See the list below. --------------------------------------------------------------- Sponsor [Between Now and June 30: Elon Musk's Next Boom?](
Tesla, Space X, Neuralink… or any other Elon Musk venture you’ve heard before. According to venture capitalist Luke Lango… His new venture is about to shock the world between now and June 30. [Click here to see the details…]( And learn how you could get started with less than $1.
--------------------------------------------------------------- [Corebridge Financial, Inc., CRBG]( - Buy to Strong Buy
Our research shows that [Corebridge Financial, Inc.]( currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $34.80. The target pricing ranges from a high forecast of $38 down to a low forecast of $33. [Corebridge Financial, Inc. (CRBG)](’s last closing price was $30.14 which would put the average price target at 15.46% upside. Other 3rd party rating services are showing the following: - TipRanks.com: Buy
- Barchart.com: Strong buy
[Click for chart >>]( [Crinetics Pharmaceuticals, Inc., CRNX]( - Buy to Strong Buy
Our research shows that [Crinetics Pharmaceuticals, Inc.]( currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $68.80. The target pricing ranges from a high forecast of $97 down to a low forecast of $52. [Crinetics Pharmaceuticals, Inc. (CRNX)](’s last closing price was $49.43 which would put the average price target at 39.19% upside. Other 3rd party rating services are showing the following: - TipRanks.com: Buy
- Barchart.com: Strong buy
[Click for chart >>]( --------------------------------------------------------------- Sponsor [China to Launch Gold-Backed Currency](
A mountain of evidence compiled over the past 20 months makes it clear to us that China will make this announcement as soon as April 6, 2024. How you handle this situation will be one of the most important financial decisions you ever make. Here are 3 steps to take right now to protect yourself - and a $2 gold mining stock that could soar 1,000% when their announcement comes. [Get the name of the micro-cap here ](
--------------------------------------------------------------- [Cirrus Logic, Inc., CRUS]( - Buy to Strong Buy
Our research shows that [Cirrus Logic, Inc.]( currently has 3 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $111.67. The target pricing ranges from a high forecast of $120 down to a low forecast of $105. [Cirrus Logic, Inc. (CRUS)](’s last closing price was $101.53 which would put the average price target at 9.98% upside. Other 3rd party rating services are showing the following: - TipRanks.com: Buy
- Barchart.com: Strong buy [Click for chart >>]( [Howmet Aerospace Inc., HWM]( - Buy to Strong Buy
Our research shows that [Howmet Aerospace Inc.]( currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $88.20. The target pricing ranges from a high forecast of $90 down to a low forecast of $85. [Howmet Aerospace Inc. (HWM)](’s last closing price was $81.13 which would put the average price target at 8.71% upside. Other 3rd party rating services are showing the following: - TipRanks.com: Buy
- Barchart.com: Strong buy [Click for chart >>]( --------------------------------------------------------------- Sponsor [Big Pharma's Worst Nightmare Could Make You Rich](
tiny firm’s patented “smart cell” technology could turn the drug industry upside down. [Click here now for details.]( --------------------------------------------------------------- [Grand Canyon Education, Inc., LOPE]( - Buy to Strong Buy
Our research shows that [Grand Canyon Education, Inc.]( currently has 3 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $161.67. The target pricing ranges from a high forecast of $170 down to a low forecast of $155. [Grand Canyon Education, Inc. (LOPE)](’s last closing price was $154.36 which would put the average price target at 4.73% upside. Other 3rd party rating services are showing the following: - TipRanks.com: Buy
- Barchart.com: Strong buy [Click for chart >>]( [McKesson Corporation, MCK]( - Buy to Strong Buy
Our research shows that [McKesson Corporation]( currently has 4 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $577.00. The target pricing ranges from a high forecast of $620 down to a low forecast of $502. [McKesson Corporation (MCK)](’s last closing price was $552.71 which would put the average price target at 4.39% upside. Other 3rd party rating services are showing the following: - TipRanks.com: Buy
- Barchart.com: Strong buy [Click for chart >>]( --------------------------------------------------------------- Sponsor [Wall Street Legend: "Do You Want to Be a Have or Have Not?"](
predicted Black Monday, the dot-com boom and the Great Recession. He's also been recognized as Barron's #1 money manager and Wall Street's #1 market timer seven years in a row. In this must-see interview, he reveals a little-known AI firm founded by two of Silicon Valley's most secretive billionaires. It's primed to dominate a $22.1 trillion-a-year boom. This is a rare opportunity to invest before this firm's valuation potentially soars 2,500% in the coming years and 5,000% within a decade. [(Full story…)]( --------------------------------------------------------------- Pricing & Percentages as of approximately 10:00am EST. To your financial freedom! The Editor MarketSectorDaily.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be third-party advertisements where the advertiser is paying per click, per lead, or per sale and are not endorsed or warranted by our staff or company. SPMG, MarketSectorDaily.com and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged not to use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. SPMG, MarketSectorDaily.com nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from SPMG or MarketSectorDaily.com to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. [If you are not a human, click here.]( By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer.
This is part of your free subscription to MarketSectorDaily.com MarketSectorDaily.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Mt. Mourne | North Carolina | 28123 | United States | 8774119808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software